Cormorant Asset Management, LP

CIK

1583977

City

BOSTON

State / Country

MA

Stock

RAPP — Rapport Therapeutics, Inc.

Top Portfolio Positions

46 positions · $2,087,175,201 total · as of Mar 31, 2026

Ticker	Company	Shares	Value (USD)	% of Portfolio	Open
PRAX	Praxis Precision Medicines, Inc. Healthcare	885,500	$285,299,245	13.67%
RAPP	Rapport Therapeutics, Inc. Healthcare	5,915,042	$185,081,664	8.87%
BBOT	BridgeBio Oncology Therapeutics, Inc. Healthcare	17,878,594	$160,013,416	7.67%
EYPT	EyePoint, Inc. Healthcare	8,265,000	$106,535,850	5.10%
EWTX	Edgewise Therapeutics, Inc. Healthcare	3,260,000	$102,690,000	4.92%
ERAS	Erasca, Inc. Healthcare	5,800,000	$93,844,000	4.50%
ALMS	Alumis Inc. Healthcare	3,949,241	$87,001,779	4.17%
ABVX	Abivax S.A. Healthcare	760,000	$84,626,000	4.05%
MLTX	MoonLake Immunotherapeutics Healthcare	4,480,433	$83,515,271	4.00%
DNTH	Dianthus Therapeutics, Inc. /DE/ Healthcare	950,000	$79,724,000	3.82%

Portfolio Trend

25 quarters · across all stocks

Holdings in RAPP

Compact Export CSV

Shares Held

Position Value (USD)

10 quarters on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$92,540,832	2,957,521	0.0%	Shares	Sole	2026-05-15
2026-03-31	$92,540,832	2,957,521	-2.3%	Shares	Defined	2026-05-15
2025-12-31	$91,854,987	3,027,521	0.0%	Shares	Defined	2026-02-17
2025-12-31	$91,854,987	3,027,521	-5.2%	Shares	Sole	2026-02-17
2025-09-30	$94,817,873	3,192,521	+8.6%	Shares	Defined	2025-11-14
2025-06-30	$33,438,271	2,940,921	0.0%	Shares	Defined	2025-08-14
2025-03-31	$29,497,437	2,940,921	0.0%	Shares	Defined	2025-05-15
2024-12-31	$52,171,938	2,940,921	0.0%	Shares	Defined	2025-02-14
2024-09-30	$60,230,062	2,940,921	+0.0%	Shares	Defined	2024-11-14
2024-06-30	$68,390,982	2,940,283	—	Shares	Defined	2024-08-14
No 13F history on record for this holder in this stock.